Company news
Valneva Se (EURONEXT:VLA) news
Valneva Se news releases on 6ix. Latest, Jul 3, 2025: VALNEVA Declaration of shares and voting rights: June 30, 2025
Press releases — page 2
VALNEVA Declaration of shares and voting rights: June 30, 2025
July 3, 2025
Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus
June 26, 2025
Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance
June 25, 2025
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®
June 5, 2025
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
June 4, 2025
Valneva to Participate at U.S. and European Investor Conferences in June
May 26, 2025
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
May 12, 2025
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
May 7, 2025
Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates
May 7, 2025